Legend Biotech Corp (LEGN) Equity Ratio (2019 - 2021)
Legend Biotech (LEGN) has disclosed Equity Ratio for 3 consecutive years, with 0.68 as the latest value for Q4 2021.
- For the quarter ending Q4 2021, Equity Ratio fell 17.35% year-over-year to 0.68, compared with a TTM value of 0.68 through Dec 2021, down 17.35%, and an annual FY2021 reading of 0.68, down 17.35% over the prior year.
- Equity Ratio was 0.68 for Q4 2021 at Legend Biotech, down from 0.83 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.83 in Q4 2020 and bottomed at 0.53 in Q4 2019.
- Average Equity Ratio over 3 years is 0.68, with a median of 0.68 recorded in 2021.
- The sharpest move saw Equity Ratio soared 57.4% in 2020, then fell 17.35% in 2021.
- Year by year, Equity Ratio stood at 0.53 in 2019, then skyrocketed by 57.4% to 0.83 in 2020, then dropped by 17.35% to 0.68 in 2021.
- Business Quant data shows Equity Ratio for LEGN at 0.68 in Q4 2021, 0.83 in Q4 2020, and 0.53 in Q4 2019.